Kolexia
Houdu Benjamin
Médecine nucléaire
Selarl D'imagerie Metabolique 1450 Par Abreviation Sim 1450
Caen, France
20 Activités
124 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Adénomes Tumeurs de la parathyroïde Hyperparathyroïdie Hyperparathyroïdie primitive Tumeurs de l'anus Tumeurs du poumon Dyspnée Cicatrice COVID-19

Industries

Spectrum Dynamics
2 collaboration(s)
Dernière en 2020
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Quantitative impact of the first COVID-19 lockdown on nuclear medicine in France: the CORALINE study.
European journal of nuclear medicine and molecular imaging   24 juin 2021
Revisiting detection of in-transit metastases in melanoma patients using digital F-FDG PET/CT with small-voxel reconstruction.
Annals of nuclear medicine   26 mars 2021
How fast can we scan patients with modern (digital) PET/CT systems?
European journal of radiology   20 juin 2020
Correction to: Why harmonization is needed when using FDG PET/CT as a prognosticator: demonstration with EARL-compliant SUV as an independent prognostic factor in lung cancer.
European journal of nuclear medicine and molecular imaging   11 mai 2020
HYPHYCA: a prospective study in 613 patients conducting a comprehensive analysis for predictive factors of physiological F-FDG anal uptake.
EJNMMI research   20 mars 2020
HYPHYCA: Identification of Predictive Factors for Physiological Hypermetabolism of the Anal Canal in 18F-FDG PET / CT
Essai Clinique (Centre François-Baclesse)   10 janvier 2019
Why harmonization is needed when using FDG PET/CT as a prognosticator: demonstration with EARL-compliant SUV as an independent prognostic factor in lung cancer.
European journal of nuclear medicine and molecular imaging   14 septembre 2018
Caractérisation des adénopathies médiastinales en TEP/TDM au 18F-FDG
Médecine Nucléaire   01 juillet 2018
APACH1: Interest of the F18-choline as a Second Line of the Tracer for Detection of Parathyroid Adenomas
Essai Clinique (Centre François-Baclesse)   02 janvier 2018
F18-choline PET/CT guided surgery in primary hyperparathyroidism when ultrasound and MIBI SPECT/CT are negative or inconclusive: the APACH1 study.
European journal of nuclear medicine and molecular imaging   22 décembre 2017